Clinical Trial Update: Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

View source ↗

Summary

This Clinical Trials update reports real-world outcomes for patients with metastatic HER2-negative breast cancer who were treated with first-line endocrine ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitor

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced/Metastatic HER2-negative Breast Cancer | Status: COMPLETED